CMTM6 antibody Usage And Synthesis

Source

Rabbit

Reactivity

Human;Mouse

Background

CKLF-like MARVEL transmembrane domain-containing protein 6 is a member of the chemokine-like factor-like MARVEL transmembrane domain-containing family. CMTM6 stabilizes plasma membrane expression of PD-L1, an immune inhibitory ligand critical for immune tolerance to self and anti-tumor immunity. CMTM6 associates with PD-L1 at recycling endosomes, where it protects PD-L1 from being targeted for lysosomal degradation by preventing STUB1-mediated PD-L1 ubiquitination. CMTM6 may stabilize PD-L1 expression on antigen presenting cells and potentiate inhibitory signaling by PD-1 on T cells, triggering T cell inhibition and exhaustion. CMTM6 has also been shown to interact with CD58, ARG1, ENO1, and TMPO. Due to the role of CMTM6 in regulating the immune system, it is being investigated as an immunotherapeutic target for the treatment of cancer.

References

[1] Han, W. et al. (2003) Genomics 81, 609-17.
[2] Burr, M.L. et al. (2017) Nature 549, 101-5.
[3] Mezzadra, R. et al. (2017) Nature 549, 106-10.

CMTM6 antibody()Related Product Information

• GMPR Antibody
• ABI3BP antibody
• FBXO34 antibody
• GABRR1 antibody
• MAP2 antibody
• PTPA antibody
• HEPH Antibody
• FBN1 Antibody
• PTGS1 antibody
• NPR1 Antibody